Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2

被引:148
作者
Bhattacharya, R
SenBanerjee, S
Lin, ZY
Mir, S
Hamik, A
Wang, P
Mukherjee, P
Mukhopadhyay, D
Jain, MK [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Program Cardiovasc Transcriptional Biol, Boston, MA 02115 USA
[2] Mayo Clin & Mayo Fdn, Mayo Clin Canc Ctr, Rochester, MN 55905 USA
关键词
D O I
10.1074/jbc.C500200200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Kruppel-like factor KLF2 was recently identified as a novel regulator of endothelial pro-inflammatory and pro-thrombotic function. Here it is shown that overexpression of KLF2 potently inhibits vascular permeability factor/vascular endothelial growth factor (VEGFA)mediated angiogenesis and tissue edema in the nude ear mouse model of angiogenesis. In vitro, KLF2 expression retards VEGF-mediated calcium flux, proliferation and induction of pro-inflammatory factors in endothelial cells. This effect is due to a potent inhibition of VEGFR2/KDR expression and promoter activity. These observations identify KLF2 as a regulator of VEGFR2/KDR and provide a foundation for novel approaches to regulate angiogenesis.
引用
收藏
页码:28848 / 28851
页数:4
相关论文
共 41 条
[21]   Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function [J].
Lin, ZY ;
Kumar, A ;
SenBanerjee, S ;
Staniszewski, K ;
Parmar, K ;
Vaughan, DE ;
Gimbrone, MA ;
Balasubramanian, V ;
García-Cardeña, G ;
Jain, MK .
CIRCULATION RESEARCH, 2005, 96 (05) :E48-E57
[22]  
Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21
[23]   A RECEPTOR TYROSINE KINASE CDNA ISOLATED FROM A POPULATION OF ENRICHED PRIMITIVE HEMATOPOIETIC-CELLS AND EXHIBITING CLOSE GENETIC-LINKAGE TO C-KIT [J].
MATTHEWS, W ;
JORDAN, CT ;
GAVIN, M ;
JENKINS, NA ;
COPELAND, NG ;
LEMISCHKA, IR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9026-9030
[24]   HIGH-AFFINITY VEGF BINDING AND DEVELOPMENTAL EXPRESSION SUGGEST FLK-1 AS A MAJOR REGULATOR OF VASCULOGENESIS AND ANGIOGENESIS [J].
MILLAUER, B ;
WIZIGMANNVOOS, S ;
SCHNURCH, H ;
MARTINEZ, R ;
MOLLER, NPH ;
RISAU, W ;
ULLRICH, A .
CELL, 1993, 72 (06) :835-846
[25]   Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling [J].
Mukhopadhyay, D ;
Zeng, HY ;
Bhattacharya, R .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 264 (1-2) :51-61
[26]  
PAJUSOLA K, 1992, CANCER RES, V52, P5738
[27]   CLOTTING AND FUNCTIONAL-ANALYSIS OF THE PROMOTER FOR KDR/FLK-1, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
PATTERSON, C ;
PARRELLA, MA ;
HSIEH, CM ;
YOSHIZUMI, M ;
LEE, ME ;
HABER, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) :23111-23118
[28]   Nuclear protein interactions with the human KDR/flk-1 promoter in vivo - Regulation of Sp1 binding is associated with cell type-specific expression [J].
Patterson, C ;
Wu, YX ;
Lee, ME ;
DeVault, JD ;
Runge, MS ;
Haber, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8410-8416
[29]   Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor [J].
Pettersson, A ;
Nagy, JA ;
Brown, LF ;
Sundberg, C ;
Morgan, E ;
Jungles, S ;
Carter, R ;
Krieger, JE ;
Manseau, EJ ;
Harvey, VS ;
Eckelhoefer, IA ;
Feng, D ;
Dvorak, AM ;
Mulligan, RC ;
Dvorak, HF .
LABORATORY INVESTIGATION, 2000, 80 (01) :99-115
[30]  
PLATE KH, 1993, CANCER RES, V53, P5822